Pharmacology - chapter 7 - Adrenergic antagonists Flashcards
phenoxybenzamine therapeutic uses?
pheochromocytoma, raynauds disease, frostbite, acrocyanosis.
Phenoxybezamine?
Irreversible & noncompetitive inhibitor of alpha-1 and alpha-2 receptors.
Phentolamine?
competitive block of alpha-1 & alpha-2 receptors used to treat hypertensive crisis.
Prazosin, Terazosin, Doxazosin, Tamsulosin and Alfuzosin ?
Selcetive competitive blockers of the lpha-1 receptor.
Tamsulosin & alfuzosin therapeutic uses?
Benign Prostatic hyperplasia
Prazosin, Terazosin and Doxazosin therapeutical use?
used to treat hypertension. By inhibiting alpha-receptors these drugs inhibit vasoconstriction = vasodilates. They also bind alpha receptors in adipose tissue and in liver, improving lipidprofiles and glucose metabolism in hypertensive patients.
What is “first-dose” effect?
E.g. Prazosin, terazosin and doxazosin may produce a orthostatic hypotensive response when the first dose is administered.
How to avoid “first-dose” response?
lower the first dose to 1/3rd or 1/4th of normal dose, and give drug at bedtime.
5alpha-reductase?
convert testosterone to dihydrotestosterone
Finasteride and dutasteride?
5 alpha-reductase inhibitors used to treat benign prostatic hyperplasia
A humongously horribly disastrous sideeffect of Finasteride and duasteride?
sexual dysfunction
Yohimbine?
Found as a component of the bark of the yohimbe tree. It’s a selective competitive alpha2-blocker. Works at the level of the CNS to increase sympathetic outflow.
All clinically available beta blockers are… ?
competitive antagonists
with exception of labetalol and carvediol, the name of all beta blosker end in …..?
“-olol”
Propranolol?
Beta-1 and beta-2 blocker
Effects of propanolol? 1 cardiovascular 2 respiratory 3 kidney 4 glucose
1 cardiovascular - lowers CO with negative iono-and chronotrophic effects. Prevents beta-2 mediated vasodilation = vasoconstriction.
2 respiratory - bronchoconstriction
3 decreased renal perfusion increses Na-retention.
4 glucose - beta-blockade leads to decreased glycogenolysis and glucagon secretion.
Conditions where you never treat with propranolol?
Asthma or COPD patients.
beta blockers in asthmatic diabetes patient?
use cardioselective betablockers